| Franciscan Inpatient Team (fit) | |
|
34515 9th Ave S Federal Way WA 98003-6761 | |
| (252) 426-6341 | |
| (253) 426-6344 |
| Full Name | Franciscan Inpatient Team (fit) |
|---|---|
| Speciality | Internal Medicine |
| Location | 34515 9th Ave S, Federal Way, Washington |
| Authorized Official Name and Position | Mike Fitzgerald (VP, FINANCIAL OPS) |
| Authorized Official Contact | 2535524105 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Franciscan Inpatient Team (fit) 1717 S J St Tacoma WA 98405-4933 Ph: (252) 426-6341 | Franciscan Inpatient Team (fit) 34515 9th Ave S Federal Way WA 98003-6761 Ph: (252) 426-6341 |
| NPI Number | 1326058017 |
|---|---|
| Provider Enumeration Date | 08/08/2006 |
| Last Update Date | 02/05/2009 |
| Medicare PECOS PAC ID | 7012813421 |
|---|---|
| Medicare Enrollment ID | O20031208000806 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326058017 | NPI | - | NPPES |
| 0125745 | Other | WA | STATE L&I |
| 8934342 | Other | VA | STATE CRIME VICTIMS |
| 7094642 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD00013079 (Washington) | Primary |
| Provider Name | Samakshi Krishna |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1255431664 PECOS PAC ID: 2567352289 Enrollment ID: I20040317000623 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Eller C Manlapaz |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1932116076 PECOS PAC ID: 1052308087 Enrollment ID: I20040429001296 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Ahmad Abadullah |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1225005721 PECOS PAC ID: 1052301306 Enrollment ID: I20040517001538 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Jude Gerard D Verzosa |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1770598112 PECOS PAC ID: 8325024391 Enrollment ID: I20040629000909 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Cuong P Nguyen |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1790882686 PECOS PAC ID: 7911979505 Enrollment ID: I20040812001139 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Fizzah M Ali |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1265524961 PECOS PAC ID: 6507801016 Enrollment ID: I20050624000789 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Michael J Kelly |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1649343278 PECOS PAC ID: 1254376775 Enrollment ID: I20050624000864 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Laurie Tyo |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1902853229 PECOS PAC ID: 2365476579 Enrollment ID: I20050926001162 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Jose Jeffrey T Reasol |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1033152855 PECOS PAC ID: 8527089200 Enrollment ID: I20051208000940 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Denise Cinciripini |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1104863281 PECOS PAC ID: 2769423425 Enrollment ID: I20060612000315 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Juan C Iregui |
|---|---|
| Provider Type | Practitioner - Hospice/palliative Care |
| Provider Identifiers | NPI Number: 1336191618 PECOS PAC ID: 1254318009 Enrollment ID: I20061020000540 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Nallathimmayyagari S Reddy |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1689763732 PECOS PAC ID: 7618977786 Enrollment ID: I20070115000164 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Emad N Girgis |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1235146077 PECOS PAC ID: 8820197734 Enrollment ID: I20070712000594 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Marco L Cruz |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1619170511 PECOS PAC ID: 3274633565 Enrollment ID: I20070716000635 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Maggie Sekeramayi |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1801099791 PECOS PAC ID: 8325148554 Enrollment ID: I20070717000296 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Danhua K Wallace |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1134320401 PECOS PAC ID: 4587765128 Enrollment ID: I20070725000774 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Amir M Aref |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1063522126 PECOS PAC ID: 3971692427 Enrollment ID: I20071205000553 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Nikolay Genchev Kolev |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1699951699 PECOS PAC ID: 5496837171 Enrollment ID: I20080204000222 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Pragathy Vutla |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1952369795 PECOS PAC ID: 7012922545 Enrollment ID: I20080207000122 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Barbora Volovarova |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1144347592 PECOS PAC ID: 7416029913 Enrollment ID: I20080627000313 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Viorel V Angheloiu |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1063687234 PECOS PAC ID: 9931271616 Enrollment ID: I20080714000069 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Naushaba Marri |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1679630461 PECOS PAC ID: 6103993951 Enrollment ID: I20080922000233 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Mihee M Montstream |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1336395896 PECOS PAC ID: 3173690823 Enrollment ID: I20080922000258 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Arthur D Siek |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1326223801 PECOS PAC ID: 2264591239 Enrollment ID: I20081105000417 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Yancey A Sloane |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1760455745 PECOS PAC ID: 5890781793 Enrollment ID: I20081218000073 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Joel Peter M Tan |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1225296007 PECOS PAC ID: 8921163254 Enrollment ID: I20090219000456 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Berhane S Asfaw |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1760593057 PECOS PAC ID: 1153328976 Enrollment ID: I20090223000112 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Jennifer B Aquino |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1184746067 PECOS PAC ID: 9931253812 Enrollment ID: I20090811000604 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Evelyn A Rubin |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1407041155 PECOS PAC ID: 9739233289 Enrollment ID: I20090818000325 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Oxana V Norvell |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1134454879 PECOS PAC ID: 1153460498 Enrollment ID: I20091130000428 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Yasser M Said |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1710195904 PECOS PAC ID: 3375635154 Enrollment ID: I20100113000348 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Rebecca A Townsend |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1962502815 PECOS PAC ID: 0143111534 Enrollment ID: I20100310000683 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Ashwin B Shivakumar |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1972773950 PECOS PAC ID: 0244365294 Enrollment ID: I20100317000022 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Bob Thong |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1538352802 PECOS PAC ID: 7315072360 Enrollment ID: I20100317000036 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | David Munoz |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1447284807 PECOS PAC ID: 9234193202 Enrollment ID: I20100603000140 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Michal J Galeziok |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1861670200 PECOS PAC ID: 3476686577 Enrollment ID: I20100726000793 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Himanshu Bhutani |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1962672550 PECOS PAC ID: 6507058781 Enrollment ID: I20101006000480 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Tiffany S Christianson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1780999334 PECOS PAC ID: 0941495469 Enrollment ID: I20101110000644 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | William Shepard Finnerty |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1891097531 PECOS PAC ID: 8426239732 Enrollment ID: I20110221000069 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Nirmalya Roychowdhury |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1598935801 PECOS PAC ID: 1951467059 Enrollment ID: I20110915000405 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Jennifer S Hammon |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1144480104 PECOS PAC ID: 1456522580 Enrollment ID: I20110922000205 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Seetharam Reddy Pothi Reddy |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1730473273 PECOS PAC ID: 8123291606 Enrollment ID: I20111027000894 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Purvi S Patel |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1225248735 PECOS PAC ID: 2567521578 Enrollment ID: I20111213000382 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Harjeet S Dhillon |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1508076985 PECOS PAC ID: 4688739683 Enrollment ID: I20111222000184 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Liana M Maxa |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1548417926 PECOS PAC ID: 7719144815 Enrollment ID: I20120201000298 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Georgia L Coote |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1851678163 PECOS PAC ID: 8325205438 Enrollment ID: I20120201000409 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Audry J Kahlstrom |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1689951550 PECOS PAC ID: 4789842659 Enrollment ID: I20120223000227 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Haneen Aibak |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1932362076 PECOS PAC ID: 6103082458 Enrollment ID: I20120731000816 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Arthur T Chen |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1104927730 PECOS PAC ID: 7810960937 Enrollment ID: I20120828000648 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Vladimir V Dzhashi |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1063643542 PECOS PAC ID: 1456508126 Enrollment ID: I20120831000235 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Nathaniel L Yu Chua |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1518290931 PECOS PAC ID: 8820246291 Enrollment ID: I20120911000224 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Ishmael Ching |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1588817480 PECOS PAC ID: 2860640968 Enrollment ID: I20120914000414 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Lakeysha T Layfield |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1841458676 PECOS PAC ID: 2264578558 Enrollment ID: I20121012000705 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Nae-hwa Kim |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1699978247 PECOS PAC ID: 6800046830 Enrollment ID: I20121026000614 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Carlo Palarca |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1265762678 PECOS PAC ID: 1951551332 Enrollment ID: I20121031000178 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Sudeep R Kommidi |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1376776377 PECOS PAC ID: 5193977155 Enrollment ID: I20121220000434 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Venkata Yearva |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1699045641 PECOS PAC ID: 7214179043 Enrollment ID: I20130807000758 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Wilfred Leung |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1306018262 PECOS PAC ID: 9335312164 Enrollment ID: I20130820001070 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | David Rochelin |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1093037632 PECOS PAC ID: 1355508532 Enrollment ID: I20130904000542 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Andriy M Viter |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1528371622 PECOS PAC ID: 8426292467 Enrollment ID: I20130913000267 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Srivatsan Padmanabhan |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1497075394 PECOS PAC ID: 6002050416 Enrollment ID: I20130924000754 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Joseph R Barthelemy |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1447567011 PECOS PAC ID: 5294960985 Enrollment ID: I20131220000787 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Amit S Desai |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1922246529 PECOS PAC ID: 8022141068 Enrollment ID: I20140122000513 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Rosita Alyssa Chefetz |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1982847158 PECOS PAC ID: 5991934069 Enrollment ID: I20140213000021 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Megha Shah |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1316139876 PECOS PAC ID: 3870739121 Enrollment ID: I20140225001649 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Sriranjini Chilkunda Ramaswamy |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1578862389 PECOS PAC ID: 1557584612 Enrollment ID: I20140519002188 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Mona Shawky |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1861711210 PECOS PAC ID: 4284877903 Enrollment ID: I20140710001057 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Ankit Patel |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1316146848 PECOS PAC ID: 0143376228 Enrollment ID: I20140718001092 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Wen Zhong |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1356381537 PECOS PAC ID: 7810980752 Enrollment ID: I20140730002861 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Jihua Jia |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1629357744 PECOS PAC ID: 1456578285 Enrollment ID: I20140818002809 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Vincent Bryan Salvador |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1831455856 PECOS PAC ID: 2062632995 Enrollment ID: I20140927000546 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Brian Nguyen |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1316263064 PECOS PAC ID: 9032339627 Enrollment ID: I20141002001074 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Jay S Patel |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1396009973 PECOS PAC ID: 6507089703 Enrollment ID: I20150122001231 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Paul D Niemi |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1164812798 PECOS PAC ID: 2961721733 Enrollment ID: I20150428001885 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Ying Liu |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1528494267 PECOS PAC ID: 5496983371 Enrollment ID: I20150709000540 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Mai Vi Ha Hoang |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1760745988 PECOS PAC ID: 3870735103 Enrollment ID: I20150731016750 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Shadi Khir |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1902160534 PECOS PAC ID: 4486969797 Enrollment ID: I20150817000324 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Naseer Abbas |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1962769380 PECOS PAC ID: 0446565238 Enrollment ID: I20150824001529 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Thankam J Nair |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1952677320 PECOS PAC ID: 0547576837 Enrollment ID: I20150901002304 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Kerrylynne Smith |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1588074157 PECOS PAC ID: 6507172681 Enrollment ID: I20150903002586 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Jinsoo Chang |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1538424692 PECOS PAC ID: 5395051304 Enrollment ID: I20150904000696 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Nicolas K Veohongs |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1881955599 PECOS PAC ID: 0244547156 Enrollment ID: I20150909002284 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | James D Atkisson |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1851377303 PECOS PAC ID: 8820999717 Enrollment ID: I20151009001312 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Edward A Himes |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1942386503 PECOS PAC ID: 3072667575 Enrollment ID: I20151013001675 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Gayatri Yambem |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1093066748 PECOS PAC ID: 9931418860 Enrollment ID: I20151015002193 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Mohamed I Imam |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1497084842 PECOS PAC ID: 2961684204 Enrollment ID: I20151030000357 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Dipam Kiran Shah |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1164787131 PECOS PAC ID: 0143530139 Enrollment ID: I20151103001784 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Tamas Ungar |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1891040572 PECOS PAC ID: 2769792597 Enrollment ID: I20151106002373 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Zahid M Nawaz |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1548470354 PECOS PAC ID: 2062554983 Enrollment ID: I20151120000662 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Desiree H Lehmann |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1639426232 PECOS PAC ID: 9638470131 Enrollment ID: I20151228001710 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Ginger L Dattilo |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1639240864 PECOS PAC ID: 8820184518 Enrollment ID: I20160304001786 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Prathima K Reddy |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1710118278 PECOS PAC ID: 7810145612 Enrollment ID: I20160316000286 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Ardith L Conway |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1689850190 PECOS PAC ID: 2365571445 Enrollment ID: I20160510002320 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Mary D Harvey |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1023401627 PECOS PAC ID: 2163712142 Enrollment ID: I20160602002537 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Gurdev Singh |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1376599431 PECOS PAC ID: 2365421393 Enrollment ID: I20160615002394 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Shahrooz Zandnia |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1699030635 PECOS PAC ID: 9335433218 Enrollment ID: I20160816001425 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | William H Kim |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1184983793 PECOS PAC ID: 8820238900 Enrollment ID: I20161004001363 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Zin M Tun |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1508122136 PECOS PAC ID: 3779806161 Enrollment ID: I20161004001399 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Chitralekha Pasupuleti |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1386083533 PECOS PAC ID: 8123316098 Enrollment ID: I20161007001581 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Saman Selahi |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1174750335 PECOS PAC ID: 8224288295 Enrollment ID: I20161026001685 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Bethany L Mullins |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1548535354 PECOS PAC ID: 7416235395 Enrollment ID: I20161027001143 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Ossama Al Masalmeh |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1851654776 PECOS PAC ID: 0648571182 Enrollment ID: I20161114000718 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Bhavim Desai |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1871886721 PECOS PAC ID: 0345560108 Enrollment ID: I20161213001233 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Isma N Hussain |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1780975615 PECOS PAC ID: 5890009930 Enrollment ID: I20170103001955 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Luc L. Bouquet |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1831348333 PECOS PAC ID: 1850430539 Enrollment ID: I20170405001567 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Christopher L Lucas |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1528233582 PECOS PAC ID: 3678745940 Enrollment ID: I20170406002628 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Braden C Andersen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1598292120 PECOS PAC ID: 6406127729 Enrollment ID: I20170804002107 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Susheel R Ramasahayam |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1366763849 PECOS PAC ID: 8729236864 Enrollment ID: I20170929002581 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Celina M Georgia |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1225543622 PECOS PAC ID: 6406118389 Enrollment ID: I20180314000021 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Hrishikesh S Raut |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1861792335 PECOS PAC ID: 8820225444 Enrollment ID: I20180618001593 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Pye Phyo Aung |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1962886390 PECOS PAC ID: 4183974710 Enrollment ID: I20180831002222 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Gerome V Bolalin |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1568727238 PECOS PAC ID: 9234362260 Enrollment ID: I20181112001069 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Ling L Qiu |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1134171317 PECOS PAC ID: 9739166133 Enrollment ID: I20181211001770 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | John S Van Taunay |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1457746539 PECOS PAC ID: 8820333248 Enrollment ID: I20181212003488 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Mary Jane S Belderol |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1255696134 PECOS PAC ID: 2769798404 Enrollment ID: I20190221001566 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Julius Larosa |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1780605071 PECOS PAC ID: 2466477997 Enrollment ID: I20190301000850 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | Emily Yc Yeh |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1528486578 PECOS PAC ID: 0244508877 Enrollment ID: I20190305002877 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
| Provider Name | John G Stam |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1326269655 PECOS PAC ID: 0547324550 Enrollment ID: I20190402001339 |
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
News Archive
Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® (exenatide) injection taken twice daily, in patients with type 2 diabetes.
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications. These strategies, published May 5 in the journal Translational Psychiatry, incorporate a new understanding of how to mitigate the risk of suicide while on SSRI treatment.
Can watching dramatic television make you fat? Yes, according to a new Cornell Food and Brand Lab study published this week in the Journal of the American Medical Association: Internal Medicine. The study finds that fast-paced television programs might lead people to eat twice as much food.
› Verified 5 days ago
Pacific Medical Centers Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 31833 Gateway Center Blvd S, Federal Way, WA 98003 Phone: 253-214-1920 | |
Adult Health And Wellness, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 33650 6th Ave S, Suite 100, Federal Way, WA 98003 Phone: 253-942-3306 Fax: 253-815-8805 | |
Northwest Observation Associates Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 34515 9th Ave S, Federal Way, WA 98003 Phone: 865-693-1000 | |
One Medical Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1414 S. 324th Street, Federal Way, WA 98003 Phone: 253-220-3121 | |
Sound Internal And Aesthetic Medicine Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 34716 1st Ave S, Federal Way, WA 98003 Phone: 253-517-7058 | |
Auburn Regional Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 34520 16th Ave S, Federal Way, WA 98003 Phone: 253-656-0223 Fax: 253-872-7900 | |
Myomedi Chiropractic Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 31260 Pacific Hwy S Ste 9, Federal Way, WA 98003 Phone: 253-528-0172 Fax: 253-528-0173 |